Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
AstraZeneca Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
AstraZeneca Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
AstraZeneca Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
AstraZeneca Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
AstraZeneca Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
AstraZeneca Plc, Medical Equipment, Deal Details 15
Venture Financing 15
Rani Therapeutics Raises Funds in Financing 15
Definiens Raises USD20.3 Million in Venture Financing Round 17
CeraPedics Raises US$19 Million In Series C Financing 18
Definiens Raises US$13 Million In Venture Financing 19
Partnerships 20
AstraZeneca Enters into Licensing Agreement with Pelago Bioscience 20
AstraZeneca Enters into Agreement with Genedata 21
Definiens Enters into Co-Development Agreement with Merck 22
Emulate Enters into Partnership Agreement with AstraZeneca 23
Procella Therapeutics and Smartwise Enter into Development Agreement with AstraZeneca 24
Chembio Diagnostic Enters into Agreement with AstraZeneca 25
Trovagene Enters into Agreement with AstraZeneca 26
AstraZeneca Enters into Partnership with DNAnexus 27
NeoGenomics and Definiens Enter into Agreement 28
SenzaGen Enters into Agreement with AstraZeneca 29
Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 30
AgPlus Diagnostics Enters into Agreement with AstraZeneca 31
Indivumed Partners with Definiens 32
Foundation Medicine Enters into Agreement with AstraZeneca 33
Definiens Partners with MolecularMD 34
MedImmune Enters into Agreement with Genisphere 35
Human Longevity Partners with AstraZeneca 36
PROOF Centre Partners with AstraZeneca 37
Cepheid, MedImmune and Combacte Enter into Agreement 38
Labcyte Enters into Agreement with AstraZeneca 39
HighRes Biosolutions Enters into Agreement with AstraZeneca 40
AstraZeneca Enters into Research Agreement with Sutter Health 41
Myriad Genetics Expands Agreement with AstraZeneca 42
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 43
AstraZeneca Enters into Co-Development Agreement with Qiagen 44
AstraZeneca Enters into Co-Development Agreement with Roche 45
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 46
Ventana Medical Enters into Co-Development Agreement with MedImmune 47
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 48
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 49
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 50
AstraZeneca Enters Into Research Agreement With Karolinska Institutet 51
Merger 52
AstraZeneca Rumored To Merge With Amgen 52
Equity Offering 53
OnDosis Spins Out from AstraZeneca 53
Debt Offering 54
AstraZeneca Prices Public Offering of 3.5% Notes due 2023 for USD0.85 Billion 54
AstraZeneca Prices Public Offering of 4% Notes due 2029 for USD1 Billion 56
AstraZeneca Prices Public Offering of 4.375% Notes due 2048 for USD0.75 Billion 58
AstraZeneca Prices Public Offering of Floating Rate Notes due 2023 for USD0.4 Billion 60
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 62
Acquisition 63
AstraZeneca to Acquire Additional 5.7% Stake in Circassia Pharma 63
Pfizer May Increase Bid to Acquire AstraZeneca 64
MedImmune Acquires Definiens for USD150 Million 66
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 67
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 69
AstraZeneca Plc – Key Competitors 70
AstraZeneca Plc – Key Employees 71
AstraZeneca Plc – Locations And Subsidiaries 74
Head Office 74
Other Locations & Subsidiaries 74
Joint Venture 80
Recent Developments 81
Strategy And Business Planning 81
Oct 01, 2017: Molnlycke to establish R&D innovation unit in AstraZeneca’s BioVentureHub 81
Apr 25, 2017: AstraZeneca marks a key milestone with the ‘topping out’ of new global R&D centre and HQ in Cambridge, UK 82
Financial Announcements 84
Jul 26, 2018: AstraZeneca announces H1 2018 results 84
May 18, 2018: AstraZeneca: Q1 2018 Results 98
Feb 02, 2018: AstraZeneca: Full-Year 2017 Results 100
Nov 09, 2017: AstraZeneca Announces Year-To-Date and Q3 2017 Results 102
Jul 27, 2017: AstraZeneca Announce H1 2017 Results 110
Apr 27, 2017: AstraZeneca Announces Q1 2017 Results 120
Feb 02, 2017: Astrazeneca Announces Full-Year and Q4 2016 Results 121
Corporate Communications 122
Sep 06, 2018: AstraZeneca: Directorate change 122
Jun 26, 2018: AstraZeneca Announces Board Committee Changes 123
Apr 05, 2018: AstraZeneca: Non-Executive Directors’ Retirement Plans 124
Dec 01, 2017: Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer 125
Sep 05, 2017: Astrazeneca Appoints Sheri Mccoy and Deborah Disanzo to its Board 126
Aug 16, 2017: Astrazeneca Non-executive Director Retirement 128
Jul 31, 2017: AstraZeneca and MedImmune strengthen immuno-oncology leadership with appointment of two renowned experts31 July 2017 129
Jun 29, 2017: Astra Zeneca: Outcome of the meeting of board of directors held on June 29, 2017 130
May 31, 2017: AstraZeneca appoints Professor Nazneen Rahman to its Board of Directors and Science Committee 131
Mar 06, 2017: Changes to AstraZeneca Board of Directors 132
Legal and Regulatory 133
Aug 01, 2018: AstraZeneca faces US DOJ probe for alleged funding of Iraqi terrorists 133
Product News 134
Jul 09, 2018: Microsoft and Partners Showcase a New ‘Molecule’ for Better Health Outcomes 134
Other Significant Developments 135
Jul 10, 2018: Revon Systems’ Digital Therapeutics Enters Collaboration with AstraZeneca in Respiratory Medicine 135
Jan 25, 2018: ACT Genomics collaborates with AstraZeneca on BRCA testing 136
Nov 01, 2017: CN Bio Innovations announces research collaboration with AstraZeneca to validate a new in vitro tool to predict optimised drug dosing regimens for multi-drug therapies 137
Sep 27, 2017: Inhalation Sciences gets large order from AstraZeneca 138
Jun 06, 2017: AstraZeneca Selects ArisGlobal LifeSphere Safety – Risk Management 139
Mar 31, 2017: First Collaborative Definition of Patient Centricity, Co-created by AstraZeneca with Patients and Carers, Is Published in British Medical Journal 140
Appendix 141
Methodology 141
About GlobalData 141
Contact Us 141
Disclaimer 141
AstraZeneca Plc, Medical Equipment, Key Facts, 2017 2
AstraZeneca Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AstraZeneca Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
AstraZeneca Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
AstraZeneca Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
AstraZeneca Plc, Deals By Market, 2012 to YTD 2018 11
AstraZeneca Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Rani Therapeutics Raises Funds in Financing 15
Definiens Raises USD20.3 Million in Venture Financing Round 17
CeraPedics Raises US$19 Million In Series C Financing 18
Definiens Raises US$13 Million In Venture Financing 19
AstraZeneca Enters into Licensing Agreement with Pelago Bioscience 20
AstraZeneca Enters into Agreement with Genedata 21
Definiens Enters into Co-Development Agreement with Merck 22
Emulate Enters into Partnership Agreement with AstraZeneca 23
Procella Therapeutics and Smartwise Enter into Development Agreement with AstraZeneca 24
Chembio Diagnostic Enters into Agreement with AstraZeneca 25
Trovagene Enters into Agreement with AstraZeneca 26
AstraZeneca Enters into Partnership with DNAnexus 27
NeoGenomics and Definiens Enter into Agreement 28
SenzaGen Enters into Agreement with AstraZeneca 29
Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 30
AgPlus Diagnostics Enters into Agreement with AstraZeneca 31
Indivumed Partners with Definiens 32
Foundation Medicine Enters into Agreement with AstraZeneca 33
Definiens Partners with MolecularMD 34
MedImmune Enters into Agreement with Genisphere 35
Human Longevity Partners with AstraZeneca 36
PROOF Centre Partners with AstraZeneca 37
Cepheid, MedImmune and Combacte Enter into Agreement 38
Labcyte Enters into Agreement with AstraZeneca 39
HighRes Biosolutions Enters into Agreement with AstraZeneca 40
AstraZeneca Enters into Research Agreement with Sutter Health 41
Myriad Genetics Expands Agreement with AstraZeneca 42
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 43
AstraZeneca Enters into Co-Development Agreement with Qiagen 44
AstraZeneca Enters into Co-Development Agreement with Roche 45
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 46
Ventana Medical Enters into Co-Development Agreement with MedImmune 47
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 48
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 49
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 50
AstraZeneca Enters Into Research Agreement With Karolinska Institutet 51
AstraZeneca Rumored To Merge With Amgen 52
OnDosis Spins Out from AstraZeneca 53
AstraZeneca Prices Public Offering of 3.5% Notes due 2023 for USD0.85 Billion 54
AstraZeneca Prices Public Offering of 4% Notes due 2029 for USD1 Billion 56
AstraZeneca Prices Public Offering of 4.375% Notes due 2048 for USD0.75 Billion 58
AstraZeneca Prices Public Offering of Floating Rate Notes due 2023 for USD0.4 Billion 60
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 62
AstraZeneca to Acquire Additional 5.7% Stake in Circassia Pharma 63
Pfizer May Increase Bid to Acquire AstraZeneca 64
MedImmune Acquires Definiens for USD150 Million 66
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 67
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 69
AstraZeneca Plc, Key Competitors 70
AstraZeneca Plc, Key Employees 71
AstraZeneca Plc, Subsidiaries 74
AstraZeneca Plc, Joint Venture 80
List of Figures
AstraZeneca Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AstraZeneca Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AstraZeneca Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AstraZeneca Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AstraZeneca Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
AstraZeneca Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
AstraZeneca Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
AstraZeneca Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11